IBDEI04W ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6239,1,4,0)
 ;;=4^HTN HRT/REN w/ RENAL FAILURE,NOS
 ;;^UTILITY(U,$J,358.3,6239,2)
 ;;=^334250
 ;;^UTILITY(U,$J,358.3,6240,0)
 ;;=404.01^^37^442^5
 ;;^UTILITY(U,$J,358.3,6240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6240,1,3,0)
 ;;=3^404.01
 ;;^UTILITY(U,$J,358.3,6240,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ CHF
 ;;^UTILITY(U,$J,358.3,6240,2)
 ;;=^334243
 ;;^UTILITY(U,$J,358.3,6241,0)
 ;;=404.03^^37^442^6
 ;;^UTILITY(U,$J,358.3,6241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6241,1,3,0)
 ;;=3^404.03
 ;;^UTILITY(U,$J,358.3,6241,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ CHF&RF
 ;;^UTILITY(U,$J,358.3,6241,2)
 ;;=^334245
 ;;^UTILITY(U,$J,358.3,6242,0)
 ;;=404.00^^37^442^8
 ;;^UTILITY(U,$J,358.3,6242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6242,1,3,0)
 ;;=3^404.00
 ;;^UTILITY(U,$J,358.3,6242,1,4,0)
 ;;=4^MAL HTN HRT/REN w/o CHF&RF
 ;;^UTILITY(U,$J,358.3,6242,2)
 ;;=^334273
 ;;^UTILITY(U,$J,358.3,6243,0)
 ;;=404.02^^37^442^7
 ;;^UTILITY(U,$J,358.3,6243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6243,1,3,0)
 ;;=3^404.02
 ;;^UTILITY(U,$J,358.3,6243,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,6243,2)
 ;;=^334244
 ;;^UTILITY(U,$J,358.3,6244,0)
 ;;=466.0^^37^443^2
 ;;^UTILITY(U,$J,358.3,6244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6244,1,3,0)
 ;;=3^466.0
 ;;^UTILITY(U,$J,358.3,6244,1,4,0)
 ;;=4^BRONCHITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,6244,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,6245,0)
 ;;=682.8^^37^443^3
 ;;^UTILITY(U,$J,358.3,6245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6245,1,3,0)
 ;;=3^682.8
 ;;^UTILITY(U,$J,358.3,6245,1,4,0)
 ;;=4^CELLULITIS, SITE NEC
 ;;^UTILITY(U,$J,358.3,6245,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,6246,0)
 ;;=575.10^^37^443^4
 ;;^UTILITY(U,$J,358.3,6246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6246,1,3,0)
 ;;=3^575.10
 ;;^UTILITY(U,$J,358.3,6246,1,4,0)
 ;;=4^CHOLECYSTITIS,UNSP
 ;;^UTILITY(U,$J,358.3,6246,2)
 ;;=^23341
 ;;^UTILITY(U,$J,358.3,6247,0)
 ;;=372.39^^37^443^5
 ;;^UTILITY(U,$J,358.3,6247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6247,1,3,0)
 ;;=3^372.39
 ;;^UTILITY(U,$J,358.3,6247,1,4,0)
 ;;=4^CONJUNCTIVITIS NEC
 ;;^UTILITY(U,$J,358.3,6247,2)
 ;;=^87441
 ;;^UTILITY(U,$J,358.3,6248,0)
 ;;=110.1^^37^443^6
 ;;^UTILITY(U,$J,358.3,6248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6248,1,3,0)
 ;;=3^110.1
 ;;^UTILITY(U,$J,358.3,6248,1,4,0)
 ;;=4^DERMATOPHYTOSIS OF NAIL
 ;;^UTILITY(U,$J,358.3,6248,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,6249,0)
 ;;=562.11^^37^443^7
 ;;^UTILITY(U,$J,358.3,6249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6249,1,3,0)
 ;;=3^562.11
 ;;^UTILITY(U,$J,358.3,6249,1,4,0)
 ;;=4^DIVERTICULITIS
 ;;^UTILITY(U,$J,358.3,6249,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,6250,0)
 ;;=424.99^^37^443^8
 ;;^UTILITY(U,$J,358.3,6250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6250,1,3,0)
 ;;=3^424.99
 ;;^UTILITY(U,$J,358.3,6250,1,4,0)
 ;;=4^ENDOCARDITIS NEC
 ;;^UTILITY(U,$J,358.3,6250,2)
 ;;=^87573
 ;;^UTILITY(U,$J,358.3,6251,0)
 ;;=707.15^^37^443^9
 ;;^UTILITY(U,$J,358.3,6251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6251,1,3,0)
 ;;=3^707.15
 ;;^UTILITY(U,$J,358.3,6251,1,4,0)
 ;;=4^FOOT ULCER
 ;;^UTILITY(U,$J,358.3,6251,2)
 ;;=^322148
 ;;^UTILITY(U,$J,358.3,6252,0)
 ;;=558.9^^37^443^10
 ;;^UTILITY(U,$J,358.3,6252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6252,1,3,0)
 ;;=3^558.9
 ;;^UTILITY(U,$J,358.3,6252,1,4,0)
 ;;=4^GASTROENTERITIS
 ;;^UTILITY(U,$J,358.3,6252,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,6253,0)
 ;;=042.^^37^443^1
 ;;^UTILITY(U,$J,358.3,6253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6253,1,3,0)
 ;;=3^042.
 ;;^UTILITY(U,$J,358.3,6253,1,4,0)
 ;;=4^AIDS (SYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,6253,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,6254,0)
 ;;=V08.^^37^443^11
 ;;^UTILITY(U,$J,358.3,6254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6254,1,3,0)
 ;;=3^V08.
 ;;^UTILITY(U,$J,358.3,6254,1,4,0)
 ;;=4^HIV+ (ASYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,6254,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,6255,0)
 ;;=487.1^^37^443^12
 ;;^UTILITY(U,$J,358.3,6255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6255,1,3,0)
 ;;=3^487.1
 ;;^UTILITY(U,$J,358.3,6255,1,4,0)
 ;;=4^INFLUENZA
 ;;^UTILITY(U,$J,358.3,6255,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,6256,0)
 ;;=730.00^^37^443^13
 ;;^UTILITY(U,$J,358.3,6256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6256,1,3,0)
 ;;=3^730.00
 ;;^UTILITY(U,$J,358.3,6256,1,4,0)
 ;;=4^OSTEOMYELITIS
 ;;^UTILITY(U,$J,358.3,6256,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,6257,0)
 ;;=382.9^^37^443^14
 ;;^UTILITY(U,$J,358.3,6257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6257,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,6257,1,4,0)
 ;;=4^OTITIS MEDIA NOS
 ;;^UTILITY(U,$J,358.3,6257,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,6258,0)
 ;;=614.9^^37^443^15
 ;;^UTILITY(U,$J,358.3,6258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6258,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,6258,1,4,0)
 ;;=4^PELVIC INFLAMMATORY DISEASE
 ;;^UTILITY(U,$J,358.3,6258,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,6259,0)
 ;;=462.^^37^443^16
 ;;^UTILITY(U,$J,358.3,6259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6259,1,3,0)
 ;;=3^462.
 ;;^UTILITY(U,$J,358.3,6259,1,4,0)
 ;;=4^PHARYNGITIS
 ;;^UTILITY(U,$J,358.3,6259,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,6260,0)
 ;;=486.^^37^443^17
 ;;^UTILITY(U,$J,358.3,6260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6260,1,3,0)
 ;;=3^486.
 ;;^UTILITY(U,$J,358.3,6260,1,4,0)
 ;;=4^PNEUMONIA
 ;;^UTILITY(U,$J,358.3,6260,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,6261,0)
 ;;=590.80^^37^443^18
 ;;^UTILITY(U,$J,358.3,6261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6261,1,3,0)
 ;;=3^590.80
 ;;^UTILITY(U,$J,358.3,6261,1,4,0)
 ;;=4^PYELONEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,6261,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,6262,0)
 ;;=711.00^^37^443^19
 ;;^UTILITY(U,$J,358.3,6262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6262,1,3,0)
 ;;=3^711.00
 ;;^UTILITY(U,$J,358.3,6262,1,4,0)
 ;;=4^SEPTIC JOINT
 ;;^UTILITY(U,$J,358.3,6262,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,6263,0)
 ;;=461.8^^37^443^20
 ;;^UTILITY(U,$J,358.3,6263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6263,1,3,0)
 ;;=3^461.8
 ;;^UTILITY(U,$J,358.3,6263,1,4,0)
 ;;=4^SINUSITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,6263,2)
 ;;=^269865
 ;;^UTILITY(U,$J,358.3,6264,0)
 ;;=473.8^^37^443^21
 ;;^UTILITY(U,$J,358.3,6264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6264,1,3,0)
 ;;=3^473.8
 ;;^UTILITY(U,$J,358.3,6264,1,4,0)
 ;;=4^SINUSITIS,CHRONIC
 ;;^UTILITY(U,$J,358.3,6264,2)
 ;;=^269890
 ;;^UTILITY(U,$J,358.3,6265,0)
 ;;=463.^^37^443^22
 ;;^UTILITY(U,$J,358.3,6265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6265,1,3,0)
 ;;=3^463.
 ;;^UTILITY(U,$J,358.3,6265,1,4,0)
 ;;=4^TONSILLITIS
 ;;^UTILITY(U,$J,358.3,6265,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,6266,0)
 ;;=011.90^^37^443^23
 ;;^UTILITY(U,$J,358.3,6266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6266,1,3,0)
 ;;=3^011.90
 ;;^UTILITY(U,$J,358.3,6266,1,4,0)
 ;;=4^TUBERCULOSIS
 ;;^UTILITY(U,$J,358.3,6266,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,6267,0)
 ;;=465.9^^37^443^24
 ;;^UTILITY(U,$J,358.3,6267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6267,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,6267,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,6267,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,6268,0)
 ;;=599.0^^37^443^25
 ;;^UTILITY(U,$J,358.3,6268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6268,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,6268,1,4,0)
 ;;=4^UTI
 ;;^UTILITY(U,$J,358.3,6268,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,6269,0)
 ;;=616.10^^37^443^26
 ;;^UTILITY(U,$J,358.3,6269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6269,1,3,0)
 ;;=3^616.10
 ;;^UTILITY(U,$J,358.3,6269,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,6269,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,6270,0)
 ;;=277.30^^37^444^1
 ;;^UTILITY(U,$J,358.3,6270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6270,1,3,0)
 ;;=3^277.30
 ;;^UTILITY(U,$J,358.3,6270,1,4,0)
 ;;=4^AMYLOIDOSIS NOS
 ;;^UTILITY(U,$J,358.3,6270,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,6271,0)
 ;;=277.31^^37^444^3
 ;;^UTILITY(U,$J,358.3,6271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6271,1,3,0)
 ;;=3^277.31
 ;;^UTILITY(U,$J,358.3,6271,1,4,0)
 ;;=4^FAM MEDITERRANEAN FEVER
 ;;^UTILITY(U,$J,358.3,6271,2)
 ;;=^189367
 ;;^UTILITY(U,$J,358.3,6272,0)
 ;;=277.39^^37^444^2
 ;;^UTILITY(U,$J,358.3,6272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6272,1,3,0)
 ;;=3^277.39
 ;;^UTILITY(U,$J,358.3,6272,1,4,0)
 ;;=4^AMYLOIDOSIS,OTHER
 ;;^UTILITY(U,$J,358.3,6272,2)
 ;;=^334034
 ;;^UTILITY(U,$J,358.3,6273,0)
 ;;=446.21^^37^444^4
 ;;^UTILITY(U,$J,358.3,6273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6273,1,3,0)
 ;;=3^446.21
 ;;^UTILITY(U,$J,358.3,6273,1,4,0)
 ;;=4^GOODPASTURE'S SYNDROME
 ;;^UTILITY(U,$J,358.3,6273,2)
 ;;=^52601^583.81
 ;;^UTILITY(U,$J,358.3,6274,0)
 ;;=580.0^^37^444^8
 ;;^UTILITY(U,$J,358.3,6274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6274,1,3,0)
 ;;=3^580.0
 ;;^UTILITY(U,$J,358.3,6274,1,4,0)
 ;;=4^NEPHRITIS,AC PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,6274,2)
 ;;=^270338
 ;;^UTILITY(U,$J,358.3,6275,0)
 ;;=580.4^^37^444^9
 ;;^UTILITY(U,$J,358.3,6275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6275,1,3,0)
 ;;=3^580.4
 ;;^UTILITY(U,$J,358.3,6275,1,4,0)
 ;;=4^NEPHRITIS,AC RAPIDLY PROGR
 ;;^UTILITY(U,$J,358.3,6275,2)
 ;;=^270339
 ;;^UTILITY(U,$J,358.3,6276,0)
 ;;=580.9^^37^444^7
 ;;^UTILITY(U,$J,358.3,6276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6276,1,3,0)
 ;;=3^580.9
 ;;^UTILITY(U,$J,358.3,6276,1,4,0)
 ;;=4^NEPHRITIS,AC NOS
 ;;^UTILITY(U,$J,358.3,6276,2)
 ;;=^270342
 ;;^UTILITY(U,$J,358.3,6277,0)
 ;;=582.0^^37^444^14
 ;;^UTILITY(U,$J,358.3,6277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6277,1,3,0)
 ;;=3^582.0
 ;;^UTILITY(U,$J,358.3,6277,1,4,0)
 ;;=4^NEPHRITIS,CHR PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,6277,2)
 ;;=^270347
 ;;^UTILITY(U,$J,358.3,6278,0)
 ;;=582.1^^37^444^12
 ;;^UTILITY(U,$J,358.3,6278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6278,1,3,0)
 ;;=3^582.1
